Cleared Traditional

K811914 - FLU VEN I.V. SETS

K811914 is an FDA 510(k) clearance for FLU VEN I.V. SETS, manufactured by Venusa , Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 33-day FDA review.

K811914 · Venusa , Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1981
Decision
33d
Days
Class 2
Risk

K811914 is an FDA 510(k) clearance for the FLU VEN I.V. SETS. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Venusa , Ltd. (Mchenry, US). The FDA issued a Cleared decision on August 3, 1981 after a review of 33 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Venusa , Ltd. devices

FDA 510(k) Submission Details - K811914

510(k) Number K811914 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 1981
Decision Date August 03, 1981
Days to Decision 33 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 129d · This submission: 33d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 514
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K811914.
QI 1150-1T INFUSION T
K812688 · Quinton, Inc. · Oct 1981
30-30-2 700 SYRINGE EXTENSION SET
K811885 · Y · Aug 1981
INTRAVENOUS ADMINISTRATION SET
K812231 · Cordis Corp. · Aug 1981
RADIATION STERILIZED ADMIN. SET
K811078 · Travenol Laboratories, S.A. · Jul 1981
I.V. ADMINISTRATION SET
K811685 · Quest Medical, Inc. · Jun 1981
IV SETS
K811107 · Critikon Company, LLC · Jun 1981